000 | 01487 a2200433 4500 | ||
---|---|---|---|
005 | 20250511193654.0 | ||
264 | 0 | _c19920626 | |
008 | 199206s 0 0 eng d | ||
022 | _a0006-2952 | ||
024 | 7 |
_a10.1016/0006-2952(92)90640-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStephan, Z F | |
245 | 0 | 0 |
_aReduction of cardiovascular and thyroxine-suppressing activities of L-T3 by liver targeting with cholic acid. _h[electronic resource] |
260 |
_bBiochemical pharmacology _cMay 1992 |
||
300 |
_a1969-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnticholesteremic Agents _xpharmacology |
650 | 0 | 4 |
_aCardiovascular System _xdrug effects |
650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
650 | 0 | 4 |
_aCholesterol _xblood |
650 | 0 | 4 | _aCholic Acid |
650 | 0 | 4 |
_aCholic Acids _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Strains |
650 | 0 | 4 |
_aReceptors, Thyroid Hormone _xmetabolism |
650 | 0 | 4 |
_aThyroxine _xantagonists & inhibitors |
650 | 0 | 4 |
_aTriiodothyronine _xpharmacology |
700 | 1 | _aYurachek, E C | |
700 | 1 | _aSharif, R | |
700 | 1 | _aWasvary, J M | |
700 | 1 | _aSteele, R E | |
700 | 1 | _aHowes, C | |
773 | 0 |
_tBiochemical pharmacology _gvol. 43 _gno. 9 _gp. 1969-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-2952(92)90640-5 _zAvailable from publisher's website |
999 |
_c1602768 _d1602768 |